NO20084583L - Makrosykliske kinase-inhibitorer - Google Patents
Makrosykliske kinase-inhibitorerInfo
- Publication number
- NO20084583L NO20084583L NO20084583A NO20084583A NO20084583L NO 20084583 L NO20084583 L NO 20084583L NO 20084583 A NO20084583 A NO 20084583A NO 20084583 A NO20084583 A NO 20084583A NO 20084583 L NO20084583 L NO 20084583L
- Authority
- NO
- Norway
- Prior art keywords
- kinase inhibitors
- macrocyclic kinase
- macrocyclic
- useful
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79978606P | 2006-05-11 | 2006-05-11 | |
US81726006P | 2006-06-28 | 2006-06-28 | |
US11/729,327 US7601852B2 (en) | 2006-05-11 | 2007-03-27 | Macrocyclic kinase inhibitors |
PCT/US2007/008591 WO2007133352A2 (fr) | 2006-05-11 | 2007-04-05 | Inhibiteurs de kinase macrocycliques |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20084583L true NO20084583L (no) | 2008-12-04 |
Family
ID=38685942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20084583A NO20084583L (no) | 2006-05-11 | 2008-11-03 | Makrosykliske kinase-inhibitorer |
Country Status (6)
Country | Link |
---|---|
US (1) | US7601852B2 (fr) |
EP (1) | EP2015745A4 (fr) |
JP (1) | JP2009536946A (fr) |
CN (1) | CN101489547B (fr) |
NO (1) | NO20084583L (fr) |
WO (1) | WO2007133352A2 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8546404B2 (en) * | 2005-12-13 | 2013-10-01 | Merck Sharp & Dohme | Compounds that are ERK inhibitors |
KR20080103996A (ko) * | 2006-02-16 | 2008-11-28 | 쉐링 코포레이션 | Erk 억제제로서 피롤리딘 유도체 |
CA2706453A1 (fr) * | 2007-11-30 | 2009-06-11 | Schering Corporation | Biomarqueurs braf |
RU2525389C2 (ru) * | 2008-02-21 | 2014-08-10 | Мерк Шарп И Доум Корп. | Соединения, которые являются ингибиторами erk |
KR20120093220A (ko) | 2009-09-16 | 2012-08-22 | 아빌라 테라퓨틱스, 인크. | 단백질 키나아제 컨쥬게이트 및 인히비터 |
AU2010299835A1 (en) * | 2009-09-28 | 2012-04-05 | Centre National De La Recherche Scientifique | Irreversible inhibitors useful for the treatment of kinase-related pathologies |
KR20130067487A (ko) | 2009-12-30 | 2013-06-25 | 아빌라 테라퓨틱스, 인크. | 단백질의 리간드-지정 공유 변형 |
US9428845B1 (en) | 2010-12-28 | 2016-08-30 | Warp Drive Bio, Inc. | Identifying new therapeutic agents |
CN103173529B (zh) | 2011-12-23 | 2015-04-29 | 上海吉凯基因化学技术有限公司 | 人nlk基因相关的用途及其相关药物 |
GB201212690D0 (en) * | 2012-07-16 | 2012-08-29 | Cancer Res Inst Royal | Materials and methods for treating pten mutated or deficient cancer |
CN104342440A (zh) * | 2013-07-30 | 2015-02-11 | 上海交通大学医学院附属新华医院 | CDKL1基因及其siRNA和应用 |
EP4289950A3 (fr) | 2015-01-09 | 2024-01-24 | Revolution Medicines, Inc. | Composés macrocycliques participant à une liaison coopérative et leurs utilisations médicales |
US9989535B2 (en) | 2015-10-01 | 2018-06-05 | Warp Drive Bio, Inc. | Methods and reagents for analyzing protein-protein interfaces |
CN108379583B (zh) * | 2018-03-27 | 2021-08-17 | 北京大学 | 一种肿瘤转移药物治疗的靶标及其应用 |
WO2020132597A1 (fr) * | 2018-12-21 | 2020-06-25 | Revolution Medicines, Inc. | Composés participant à une liaison coopérative et utilisations associées |
CR20220240A (es) | 2019-11-04 | 2022-08-03 | Revolution Medicines Inc | Inhibidores de ras |
JP2022553858A (ja) | 2019-11-04 | 2022-12-26 | レボリューション メディシンズ インコーポレイテッド | Ras阻害剤 |
MX2022005360A (es) | 2019-11-04 | 2022-06-02 | Revolution Medicines Inc | Inhibidores de ras. |
JP2023541916A (ja) | 2020-09-15 | 2023-10-04 | レボリューション メディシンズ インコーポレイテッド | がんの治療における、ras阻害剤としてのインドール誘導体 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9225396D0 (en) | 1992-12-04 | 1993-01-27 | Sandoz Ltd | Improvements in or relating to organic compounds |
JPH0840893A (ja) | 1993-08-31 | 1996-02-13 | Takeda Chem Ind Ltd | インターロイキン−1産生抑制剤 |
US5795910A (en) * | 1994-10-28 | 1998-08-18 | Cor Therapeutics, Inc. | Method and compositions for inhibiting protein kinases |
GB2323845A (en) * | 1997-03-31 | 1998-10-07 | Merck & Co Inc | MEK inhibiting lactones |
EP1140069A1 (fr) * | 1998-12-24 | 2001-10-10 | Novation Pharmaceuticals Inc. | COMPOSES MODIFIANT LA STABILITE DE L'ARNm ET UTILISATIONS DE CES COMPOSES |
JP2001294527A (ja) | 2000-04-14 | 2001-10-23 | Ajinomoto Co Inc | Th2反応に特異的な免疫寛容誘導剤 |
JP2004292315A (ja) | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | Tak1阻害剤 |
JP2004292314A (ja) | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | ケラチノサイト増殖抑制剤 |
US7553979B2 (en) * | 2001-11-09 | 2009-06-30 | Conforma Therapeutics Corporation | HSP90-inhibiting zearalanol compounds and methods of producing and using same |
US7915306B2 (en) * | 2002-03-08 | 2011-03-29 | Eisai Co., Ltd. | Macrocyclic compounds useful as pharmaceuticals |
JP4575667B2 (ja) * | 2002-03-08 | 2010-11-04 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 医薬として有用な大環状化合物 |
CN1652743A (zh) * | 2002-04-17 | 2005-08-10 | 大正制药株式会社 | 毛发生长补剂 |
US20060094674A1 (en) * | 2002-07-05 | 2006-05-04 | Neel Benjamin G | Combination of mtor inhibitor and a tyrosine kinase inhibitor for the treatment of neoplasms |
CA2581375A1 (fr) * | 2004-09-27 | 2006-04-06 | Kosan Biosciences Incorporated | Inhibiteurs de kinases specifiques |
EP1794062A1 (fr) * | 2004-09-29 | 2007-06-13 | Iventors Express Pty Ltd | Support de boisson |
-
2007
- 2007-03-27 US US11/729,327 patent/US7601852B2/en active Active
- 2007-04-05 WO PCT/US2007/008591 patent/WO2007133352A2/fr active Application Filing
- 2007-04-05 EP EP07755007A patent/EP2015745A4/fr not_active Withdrawn
- 2007-04-05 CN CN2007800262784A patent/CN101489547B/zh not_active Expired - Fee Related
- 2007-04-05 JP JP2009509575A patent/JP2009536946A/ja active Pending
-
2008
- 2008-11-03 NO NO20084583A patent/NO20084583L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007133352A2 (fr) | 2007-11-22 |
CN101489547B (zh) | 2012-08-08 |
CN101489547A (zh) | 2009-07-22 |
US7601852B2 (en) | 2009-10-13 |
EP2015745A4 (fr) | 2011-03-09 |
JP2009536946A (ja) | 2009-10-22 |
US20070265333A1 (en) | 2007-11-15 |
EP2015745A2 (fr) | 2009-01-21 |
WO2007133352A3 (fr) | 2008-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20084583L (no) | Makrosykliske kinase-inhibitorer | |
NO20083717L (no) | Pyrrolotriazin-anilin prodrugforbindelser anvendbare som kinaseinhibitorer | |
NO20080761L (no) | Acykliske Ikur inhibitorer | |
NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
EA200801381A1 (ru) | Производные пиримидина | |
WO2005074603A3 (fr) | Utilisation d'aminobenzoxazoles comme agents therapeutiques | |
GB0521508D0 (en) | Organic compounds | |
NO20063944L (no) | Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister | |
WO2008106047A3 (fr) | Composés de carbamate | |
NO20075626L (no) | Heteroarylbenzamid-derivater for anvendelse som GLK-aktivatorer i behandling av diabetes | |
CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
CY1112467T1 (el) | Παραγωγα 1-θειο-d-γλυκιτολης | |
EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
NO20083390L (no) | Piperaziner og piperidiner som mGluR5-forsterkere | |
NO20082209L (no) | Homo- og heterocykliske forbindelser anvendbare som CETP-inhibitorer | |
NO20064032L (no) | DPP-IV inhibitorer | |
ATE483000T1 (de) | Naphtalin-amidin-imide | |
NO20071254L (no) | Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav. | |
NO20075706L (no) | Pyrrolopyridinbaserte inhibitorer av dipeptidylpeptidase IV og metoder | |
ATE553106T1 (de) | Heteroarylpyrrolopyridinone als kinaseinhibitoren | |
RS52255B (en) | NALMEFEN HYDROCHLORIDE DIHYDRATE | |
WO2006017054A3 (fr) | Composes heteroaryles tricycliques utiles en tant qu'inhibiteurs de kinase | |
NO20082116L (no) | Kjemisk fremgangsmate for fremstilling av en amido-fenoksybenzosyreforbindelse | |
NO20061317L (no) | Imidazopyridinderivater som induserbare NO-syntaseinhibatorer | |
NO20064351L (no) | Caspaseinhibitorer og anvendelser derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |